Disease-Specific Differentiation Between Drugs and Non-Drugs Using Principal Component Analysis of Their Molecular Descriptor Space. (Q36091270)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Disease-Specific Differentiation Between Drugs and Non-Drugs Using Principal Component Analysis of Their Molecular Descriptor Space (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

principal component analysis

20 March 2020

main subject

0 references

author

Alfonso T. García-Sosa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Csaba Hetényi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Uko Maran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Mare Oja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

3 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

published in

Molecular Informatics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

369-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

The properties of known drugs. 1. Molecular frameworks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Identification of biological activity profiles using substructural analysis and genetic algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Computational methods for the prediction of 'drug-likeness'

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Comparison of support vector machine and artificial neural network systems for drug/nondrug classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

A comparison of physiochemical property profiles of development and marketed oral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Selection criteria for drug-like compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Characteristic physical properties and structural fragments of marketed oral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

The influence of drug-like concepts on decision-making in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Chemical fragments as foundations for understanding target space and activity prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Drug and drug candidate building block analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

What do medicinal chemists actually make? A 50-year retrospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Property distribution of drug-related chemical databases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Descriptors, physical properties, and drug-likeness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Is there a difference between leads and drugs? A historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Chemography: the art of navigating in chemical space.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

QSAR in the pharmaceutical research setting: QSAR models for broad, large problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

A chemogenomics view on protein-ligand spaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Ligand efficiency: a useful metric for lead selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

The maximal affinity of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Ligand efficiency indices as guideposts for drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Structure-based calculation of drug efficiency indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

ChemProt: a disease chemical biology database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Molecular property filters describing pharmacokinetics and drug binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

KiBank: a database for computer-aided drug design based on protein-chemical interaction analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

The PDBbind database: methodologies and updates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

DrugBank: a comprehensive resource for in silico drug discovery and exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Survey of the year 2005: literature on applications of isothermal titration calorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Structure of a C-type mannose-binding protein complexed with an oligosaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Drug discovery beyond the 'rule-of-five'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Targeting protein kinases in central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Drug research: myths, hype and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

21 January 2018

New uses for old drugs

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Computation of octanol-water partition coefficients by guiding an additive model with knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

A general treatment of solubility. 1. The QSPR correlation of solvation free energies of single solutes in series of solvents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

A general treatment of solubility 4. Description and analysis of a PCA model for ostwald solubility coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Mechanisms involved in the side effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Structural analysis of inhibitor binding to human carbonic anhydrase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Pursuing the leadlikeness concept in pharmaceutical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Combined approach using ligand efficiency, cross-docking, and antitarget hits for wild-type and drug-resistant Y181C HIV-1 reverse transcriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Predicting drug-likeness: why and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Mining of randomly generated molecular fragment populations uncovers activity-specific fragment hierarchies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Semianalytical treatment of solvation for molecular mechanics and dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Understanding drug-likeness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100094

Development of KiBank, a database supporting structure-based drug design

21 January 2018

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100094

An internal-coordinate Monte Carlo method for searching conformational space

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100094

Scaffold distributions in bioactive molecules, clinical trials compounds, and drugs

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100094

Chemical space and biology

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100094

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100094

Dependence of molecular properties on proteomic family for marketed oral drugs

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100094

Solvents and Solvent Effects in Organic Chemistry

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100094

8 April 2023

Identifiers

DOI

10.1002/MINF.201100094

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27477266%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference